April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
EFFECTIVENESS OF ACHIEVING SINGLE DIGIT IOP TARGETS WITH FILTRATION SURGERY ON DECREASING GLOBAL AND LOCALIZED VISUAL FIELD PROGRESSION IN EYES WITH PROGRESSIVE NORMAL-TENSION GLAUCOMA
Author Affiliations & Notes
  • Shawn M Iverson
    Ophthalmology, Bascom Palmer Eye Institute - University of Miami, Palm Beach Gardens, FL
  • Scott Keith Schultz
    Ophthalmology, Bishop Eye Associates, Hilton Head Island, SC
  • Wei Shi
    Ophthalmology, Bascom Palmer Eye Institute - University of Miami, Palm Beach Gardens, FL
  • William J Feuer
    Ophthalmology, Bascom Palmer Eye Institute - University of Miami, Palm Beach Gardens, FL
  • David S Greenfield
    Ophthalmology, Bascom Palmer Eye Institute - University of Miami, Palm Beach Gardens, FL
  • Footnotes
    Commercial Relationships Shawn Iverson, None; Scott Schultz, None; Wei Shi, None; William Feuer, None; David Greenfield, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5636. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shawn M Iverson, Scott Keith Schultz, Wei Shi, William J Feuer, David S Greenfield; EFFECTIVENESS OF ACHIEVING SINGLE DIGIT IOP TARGETS WITH FILTRATION SURGERY ON DECREASING GLOBAL AND LOCALIZED VISUAL FIELD PROGRESSION IN EYES WITH PROGRESSIVE NORMAL-TENSION GLAUCOMA. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5636.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To examine the effectiveness of achieving single digit intraocular pressure (IOP) targets with glaucoma filtration surgery on decreasing global and localized visual field (VF) progression in eyes with progressive normal-tension glaucoma (NTG).

Methods: A retrospective chart review was conducted to identify NTG patients that underwent trabeculectomy with mitomycin C (MMC) between February 2006 and October 2010 for progressive VF loss with preoperative IOP ≤ 15 mmHg during the 12-months prior to surgery. All eyes had evidence of glaucomatous optic neuropathy and progressive VF loss, uncontrolled IOP on maximum medical therapy, and a minimum of 2 baseline preoperative and 4 postoperative VF examinations. Exclusion criteria consisted of age ≤ 18, recorded IOP > 22 mmHg, ocular disease other than glaucoma, prior incisional surgery except uncomplicated cataract extraction, and unreliable (>15% fixation loss or > 33% false positives or false negatives) VFs. VF progression was assessed using Guided Progression Analysis™ (GPA) and Progressor™ software (defined as ≥ 2 adjacent test locations losing ≥ 1.0 dB/year at p ≤ 0.01 for inner locations or ≥ 2.0 dB/year at p ≤ 0.01 for edge locations).

Results: Fifteen eyes of 14 patients (mean age 71.8 ± 7.5 years) were enrolled with mean follow-up of 71 ± 26 months. Mean postoperative IOP (8.5 ± 3.5 mmHg) and number of medications (0.80 ± 1.32) were significantly (p<0.001) reduced compared to prior to surgery (13.1 ± 1.5 mmHg, 2.5 ± 1.3 respectively). The mean number of VF examinations was 8.21 ± 5.11 preoperatively and 6.73 ± 3.49 postoperatively. The overall number of eyes judged to have postoperative VF progression using any method was 2 of 15 (13.3%) eyes (1 eye using Progressor™ analysis; 1 eye using both GPA™ and Progressor™). Average postoperative slope of mean deviation (-0.20 ± 0.68 dB/year) and pattern standard deviation (0.13 ± 0.29dB/year) were improved (P=0.07 and 0.08) compared to the preoperative slopes (-0.76 ± 0.76 and 0.59 ± 0.56 dB/year).

Conclusions: Achieving single digit IOP targets with filtration surgery has a beneficial effect on reducing global and localized rates of VF progression in NTG eyes with progression at low IOP.

Keywords: 568 intraocular pressure • 758 visual fields • 462 clinical (human) or epidemiologic studies: outcomes/complications  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×